1.
Quynh PNN, Nguyen PTL, Nguyen HT, Phung TL, Nguyen D, Duong K. PARP inhibitors in newly diagnosed or recurrent ovarian cancer maintenance therapy: evidence of efficacy and safety from randomized controlled trials. BMRAT [Internet]. 31Dec.2023 [cited 22Nov.2024];10(12):6090-102. Available from: http://bmrat.biomedpress.org/index.php/BMRAT/article/view/851